GlassScriptPhysician profile
Mary Anne Ost
NPI 1740249697
$4,505.91
in general payments reported to CMS, 2019-2025
24 companies · $806 in 2025
The $806 reported for 2025 was more than what 88% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $519 · 2021: $585 · 2022: $511 · 2023: $599 · 2024: $491 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,147.65 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,077.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $612.83 | 2019-2021 | |
| Pfizer INC. | $371.14 | 2019-2025 | |
| Abbvie INC. | $370.94 | 2021-2025 | |
| Glaxosmithkline, LLC. | $214.57 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Astellas Pharma US INC | $208.53 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $105.42 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $40.67 | 2019 | |
| Exact Sciences Corporation | $39.96 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boston Scientific Corporation | $38.75 | 2024-2025 | Bodyguardian |
| Takeda Pharmaceuticals U.S.A., INC. | $38.58 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.17 | 2022 | |
| Avanir Pharmaceuticals, INC. | $27.78 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $26.41 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $24.68 | 2025 | Flexitouch Plus, Nimbl |
| Idorsia Pharmaceuticals US INC | $23.52 | 2024 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $21.22 | 2025 | Rexulti |
| Genentech USA, INC. | $19.09 | 2021 | |
| Snap Diagnostics LLC | $15.90 | 2020 | |
| Amarin Pharma, INC. | $14.91 | 2019 | |
| Dexcom, INC. | $14.13 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.22 | 2019 | |
| Linus Health, INC. | $6.66 | 2024 | Core Cognitive Evaluation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Anne Ost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.